Having problems reading this email? View it in your browser >>
|
||
|
||
Contents |
||
News from aidsmap | ||
High death rate in mpox outbreak in the Democratic Republic of CongoThe Democratic Republic of the Congo is in the midst of an mpox (formerly known as monkeypox) outbreak that has led to nearly 600 deaths, according to the World Health Organization. Unlike last year’s global outbreak, this one involves a different clade of mpox virus that causes more severe disease. What’s more, sexual transmission of this strain is playing a role for the first time, especially among men who have sex with men. Differentiated HIV services improve retention in careShifting to differentiated service delivery such as fewer clinic visits, one-stop clinics and community dispensing of antiretrovirals improves retention in HIV care, a study of Mozambique’s national antiretroviral treatment programme has found. Providing sexual health services to gay men in Kenya – where gay sex is illegalKenyan healthcare providers and staff at university clinics expressed a duty of care for young gay and bisexual men – even when this conflicted with their personal beliefs and when they felt ill-equipped to do so – according to a recent qualitative study. A third of US health department websites don’t mention U=UWhile almost all state health department websites in the US provide information about PrEP, 18 do not mention ‘Undetectable equals Untransmittable’ (U=U) by name. Even when U=U is covered, there are gaps in the information provided on many of these official websites. | ||
Gene editing may not be the safest HIV cure strategy, early findings warnGene editing with CRISPR/Cas9 can lead to unwanted ‘cuts’ and changes in the gene sequences near to the integrated HIV genes, Dutch researchers report in the Journal of Virology. This might activate host genes that could contribute to cancer development, raising concerns about this potential HIV cure strategy. Intimate partner violence increases a woman’s risk of acquiring HIVA recent study suggests that intimate partner violence (IPV) increases the risk of HIV beyond what is expected for women living in sub-Saharan Africa who have male partners living with HIV. Women aged 15-24 had a 3% increase in risk when they had a partner living with HIV who perpetrated IPV, compared to women whose partner just had HIV. Men who perpetrate IPV were also shown to have higher rates of HIV. UK experts recommend statins for all people with HIV aged 40 and overThe British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised cholesterol or a high risk of heart disease. Less than 1% in US emergency departments are tested for HIVDespite recommendations for universal screening, less than 1% of people attending emergency departments in the United States are tested for HIV, with no improvement in recent years, according to a report published in the journal AIDS. | ||
HIV LensHIV Lens is an interactive online mapping tool that visualises the impact of the HIV epidemic on communities across England. The latest HIV data for England have been published on HIV Lens for World AIDS Day. You can view data such as new HIV diagnoses first made in England, HIV treatment coverage and viral suppression for the whole of England as well as by region and local authority. | ||
Thank youThank you to everyone who supported our World AIDS Day campaign this year. Your generous donations, sharing feedback, and spreading the word have helped us reach people worldwide who can benefit from our information. As a leading source of independent, accurate, and reliable information on HIV, aidsmap is committed to ensuring that everyone affected by HIV has access to life-changing information. But we can't do it alone. We rely on the support of our community to help us achieve our vision of a world where HIV is no longer a threat to health or happiness. It's not too late to show your support. From just £3 a month, you can help us provide equitable access to information and make a real difference to everyone affected by HIV. | ||
Editors' picks from other sources | ||
Top 10 HIV clinical developments of 2023 | TheBodyProThe top 10 HIV-related stories of 2023 could justifiably have all been about long-acting antiretrovirals, given the significance of this slowly unfolding revolution in HIV care. After some kicking and screaming, every-two-month intramuscular HIV therapy has become integrated within most clinics in the US. Innovative HIV prevention product for women that promotes choice – dapivirine vaginal ring – gains momentum across Africa | Population CouncilWith use approved in 11 African countries, women can access the ring now in a growing number of implementation and pilot studies across 6 of those countries. Progress continues to accelerate access to cabotegravir LA for PrEP in low- and middle-income countries | ViiV press releaseViiV Healthcare is committed to enabling access to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP). Registrations have continued with the majority of regulatory approvals received in 2023 being in low- and middle-income countries. We also received European authorisation in September 2023. It is time to streamline the global HIV/AIDS architecture | Health Policy WatchThere are many examples of organisations adjusting their work in the face of altered requirements. But never has a UN agency closed shop voluntarily. UNAIDS, at its start, pioneered UN reform. It could trail blaze again by closing its doors, say in 2030. South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs | San Francisco ChronicleSouth Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV. Despite progress, adolescent girls continue to bear the brunt of the HIV epidemic with 98,000 new infections in 2022 | UNICEFWhile total infections among girls aged 10-19 have almost halved since 2010 – from 190,000 to 98,000 – girls were still more than twice as likely to contract HIV last year, than boys. Ryan White, a poster child for AIDS obscured as much about the crisis as he revealed | TIMERyan White’s high-profile case challenged the idea that HIV/AIDS only affected IV drug users and gay men. But the narratives surrounding White and his fight to return to school frequently distinguished between “righteous” and “unrighteous” people with AIDS. Long-acting PrEP in Europe's fight against HIV | Medscape (requires free registration)Europe's advances in HIV prevention strategies, including PrEP and long-acting retrovirals, bring hope amidst persistent access challenges and disparities. Tennessee’s penalties for HIV-positive people are discriminatory, Justice Department says | NBC NewsTennessee’s aggravated prostitution statute that imposes a lifetime registration as a "violent sex offender" if convicted of engaging in sex work while living with HIV violates the Americans with Disabilities Act, the US Department of Justice says. UNAIDS urges investment in community leadership to end AIDS | Health Policy WatchAs donors withdraw from HIV, the Joint United Nations Programme on HIV/AIDS (UNAIDS) chose to focus on the importance of community-led interventions to end the AIDS pandemic for World AIDS Day on 1 December. | ||
aidsmapLIVE: World AIDS Day specialIf you missed our aidsmapLIVE World AIDS Day special last week, you can catch up on Facebook and Twitter/X. This aidsmapLIVE special focused on inequalities, and joining aidsmap's Susan Cole were: Florence Anam from the Global Network of People Living with HIV; Dr Rageshri Dhairyawan from Barts Health NHS Trust; Bruce Richman from the Prevention Access Campaign; Idris Mwendwa from Hapa Kenya; and Erika Castellanos from Global Action for Trans Equality. | ||
Have your say: conference bulletins survey 2023Each year, our writers attend the world’s leading HIV conferences to report on the latest scientific research and debates. We would love to know what you think about our conference reporting. Your feedback will help us demonstrate the impact of our global conference coverage and help us plan future activities. Please take a couple of minutes to complete our anonymous survey. | ||
Connect with us |
||
aidsmap is an award-winning, community-based organisation, which works from the UK. We deliver reliable and accurate HIV information across the world to HIV-positive people and to the professionals who treat, support and care for them.
NAM Publications
Cally Yard, 439 Caledonian Road, London N7 9BG Company limited by guarantee. Registered in England & Wales, number: 2707596 Registered charity, number: 1011220 To unsubscribe please click here Privacy Policy: www.aidsmap.com/about-us/confidentiality |